Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Basile

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Southern Medical Journal|October 11, 2001
Hypertension 2001: how will JNC VII be different from JNC VI?J N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Do blacks with ventricular dysfunction benefit from ACE inhibitor therapy?J N Basile
International Journal of Clinical Practice|February 18, 2009
Antihypertensive therapy, new-onset diabetes, and cardiovascular diseaseJ N Basile
Southern Medical Journal|June 1, 2000
Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee ReportJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 26, 2001
Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockadeJ N Basile
Southern Medical Journal|January 10, 2002
Hypertension 2001: pearls for the clinicianJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 28, 2001
Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunctionJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2001
Salt sensitivity predicts mortality independently of elevated blood pressure: a 27-year follow-up studyJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 26, 2001
An angiotensin receptor blocker plus a diuretic is most effective in lowering blood pressure in the African American with hypertension on a supplemental salt dietJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Analyzing the national cholesterol education program adult treatment panel III report: is new better?J N Basile
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Southern Medical Journal|October 11, 2001
Hypertension 2001: how will JNC VII be different from JNC VI?J N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Do blacks with ventricular dysfunction benefit from ACE inhibitor therapy?J N Basile
International Journal of Clinical Practice|February 18, 2009
Antihypertensive therapy, new-onset diabetes, and cardiovascular diseaseJ N Basile
Southern Medical Journal|June 1, 2000
Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee ReportJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 26, 2001
Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockadeJ N Basile
Southern Medical Journal|January 10, 2002
Hypertension 2001: pearls for the clinicianJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 28, 2001
Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunctionJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2001
Salt sensitivity predicts mortality independently of elevated blood pressure: a 27-year follow-up studyJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 26, 2001
An angiotensin receptor blocker plus a diuretic is most effective in lowering blood pressure in the African American with hypertension on a supplemental salt dietJ N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Analyzing the national cholesterol education program adult treatment panel III report: is new better?J N Basile
Pageof 2